Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

668
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
668
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

1.0K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When I use a word . . . Medical skepticism.

BMJ (Clinical research ed.)·2026
Same author

When I use a word . . . The Devil's Medical Dictionary.

BMJ (Clinical research ed.)·2026
Same author

When I use a word . . . Centenarians.

BMJ (Clinical research ed.)·2026
Same author

When I use a word . . . Nocebo.

BMJ (Clinical research ed.)·2026
Same author

When I use a word . . . The earliest placebo.

BMJ (Clinical research ed.)·2026
Same author

When I use a word . . . Antedatings in the <i>Oxford English Dictionary</i>.

BMJ (Clinical research ed.)·2026

Related Experiment Video

Updated: Mar 6, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.3K

Biomarkers-A General Review.

Jeffrey K Aronson1, Robin E Ferner2,3

  • 1Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Infirmary, Oxford, United Kingdom.

Current Protocols in Pharmacology
|March 18, 2017
PubMed
Summary
This summary is machine-generated.

Biomarkers are measurable biological indicators that predict clinical outcomes, offering a more accessible and cost-effective alternative to direct endpoint measurement for various applications. Understanding their pathophysiological link is key to their effective use in healthcare.

Keywords:
adverse drug reactionsbiomarkersdiagnosisdrug developmentdrug discoverymonitoring drug therapyscreeningsurrogate endpointssurrogate markers

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

892

Related Experiment Videos

Last Updated: Mar 6, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.3K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

892

Area of Science:

  • Biomedical Science
  • Clinical Research
  • Translational Medicine

Background:

  • Biomarkers are biological observations that serve as surrogates for clinically relevant endpoints.
  • Their measurement is often easier, less expensive, and faster than direct endpoint assessment.
  • Biomarkers are crucial tools in modern medical research and practice.

Purpose of the Study:

  • To define the role and utility of biomarkers in clinical settings.
  • To highlight the importance of the pathophysiological relationship between biomarkers and clinical endpoints.
  • To outline the desirable characteristics of a good biomarker.

Main Methods:

  • This abstract discusses the conceptual framework and applications of biomarkers.
  • It emphasizes the importance of understanding the underlying biological mechanisms.
  • Key characteristics of effective biomarkers are described.

Main Results:

  • Biomarkers facilitate disease screening, diagnosis, monitoring, and prognosis.
  • They are instrumental in developing personalized therapies and managing drug reactions.
  • Biomarkers aid in pharmacodynamic and dose-response studies.

Conclusions:

  • Effective biomarkers are measurable, reliable, and sensitive to therapeutic changes.
  • A strong understanding of the biomarker-endpoint relationship is essential for validation.
  • Biomarkers significantly enhance the efficiency and scope of clinical studies.